ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 59620 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 59620; 2) Community: the network communities that were significantly associated with the response to NSC 59620; 3) Molecule: the relationships between components within communities and NSC 59620; 4) MDR: the compounds that were significantly associated with the NSC 59620.

NSC Compound Enrichment Correlation
NSC 728856 5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride 0.00736331140329775 0.058465833
NSC 742939 Null 0.00736331140329775 0.19001128
NSC 761676 Null 0.00736331140329775 0.081160417
NSC 646199 Null 0.00783051864107159 0.28694454
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.00783051864107159 0.26148914
NSC 667545 Null 0.00783051864107159 0.11830489
NSC 690118 Null 0.00783051864107159 0.4311641
NSC 693986 Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, 0.00783051864107159 0.094580095
NSC 749227 Abiraterone acetate 0.00783051864107159 0.33999166
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.00783051864107159 0.23476582
Total:47  Current:7    [First] [Prev] [Next] [Last]